Report Cover

Global and United States Influenza Diagnostics Market Size, Status and Forecast 2021-2027


Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.

Market Analysis and Insights: Global Influenza Diagnostics Market
The global Influenza Diagnostics market size is projected to reach US$ 3377.2 million by 2027, from US$ 2195.6 million in 2020, at a CAGR of 6.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Diagnostics market.

Global Influenza Diagnostics Scope and Market Size
Influenza Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
    RIDT
    RT-PCR
    Cell Culture
    Others

Segment by Application
    Hospitals
    POCT
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

By Company
    BD
    Abbott (Include Alere)
    Roche
    SIEMENS
    Analytik Jena
    Quidel
    Thermo Fisher
    Meridian Bioscience
    BioMerieux
    Sekisui Diagnostics
    Response Biomedical
    SA Scientific
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 RIDT
        1.2.3 RT-PCR
        1.2.4 Cell Culture
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Influenza Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 POCT
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Influenza Diagnostics Market Perspective (2016-2027)
    2.2 Influenza Diagnostics Growth Trends by Regions
        2.2.1 Influenza Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Influenza Diagnostics Historic Market Share by Regions (2016-2021)
        2.2.3 Influenza Diagnostics Forecasted Market Size by Regions (2022-2027)
    2.3 Influenza Diagnostics Industry Dynamic
        2.3.1 Influenza Diagnostics Market Trends
        2.3.2 Influenza Diagnostics Market Drivers
        2.3.3 Influenza Diagnostics Market Challenges
        2.3.4 Influenza Diagnostics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Influenza Diagnostics Players by Revenue
        3.1.1 Global Top Influenza Diagnostics Players by Revenue (2016-2021)
        3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2016-2021)
    3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Influenza Diagnostics Revenue
    3.4 Global Influenza Diagnostics Market Concentration Ratio
        3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2020
    3.5 Influenza Diagnostics Key Players Head office and Area Served
    3.6 Key Players Influenza Diagnostics Product Solution and Service
    3.7 Date of Enter into Influenza Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Diagnostics Breakdown Data by Type
    4.1 Global Influenza Diagnostics Historic Market Size by Type (2016-2021)
    4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027)

5 Influenza Diagnostics Breakdown Data by Application
    5.1 Global Influenza Diagnostics Historic Market Size by Application (2016-2021)
    5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Influenza Diagnostics Market Size (2016-2027)
    6.2 North America Influenza Diagnostics Market Size by Type
        6.2.1 North America Influenza Diagnostics Market Size by Type (2016-2021)
        6.2.2 North America Influenza Diagnostics Market Size by Type (2022-2027)
        6.2.3 North America Influenza Diagnostics Market Size by Type (2016-2027)
    6.3 North America Influenza Diagnostics Market Size by Application
        6.3.1 North America Influenza Diagnostics Market Size by Application (2016-2021)
        6.3.2 North America Influenza Diagnostics Market Size by Application (2022-2027)
        6.3.3 North America Influenza Diagnostics Market Size by Application (2016-2027)
    6.4 North America Influenza Diagnostics Market Size by Country
        6.4.1 North America Influenza Diagnostics Market Size by Country (2016-2021)
        6.4.2 North America Influenza Diagnostics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Influenza Diagnostics Market Size (2016-2027)
    7.2 Europe Influenza Diagnostics Market Size by Type
        7.2.1 Europe Influenza Diagnostics Market Size by Type (2016-2021)
        7.2.2 Europe Influenza Diagnostics Market Size by Type (2022-2027)
        7.2.3 Europe Influenza Diagnostics Market Size by Type (2016-2027)
    7.3 Europe Influenza Diagnostics Market Size by Application
        7.3.1 Europe Influenza Diagnostics Market Size by Application (2016-2021)
        7.3.2 Europe Influenza Diagnostics Market Size by Application (2022-2027)
        7.3.3 Europe Influenza Diagnostics Market Size by Application (2016-2027)
    7.4 Europe Influenza Diagnostics Market Size by Country
        7.4.1 Europe Influenza Diagnostics Market Size by Country (2016-2021)
        7.4.2 Europe Influenza Diagnostics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Influenza Diagnostics Market Size (2016-2027)
    8.2 Asia-Pacific Influenza Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Influenza Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Influenza Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Influenza Diagnostics Market Size (2016-2027)
    9.2 Latin America Influenza Diagnostics Market Size by Type
        9.2.1 Latin America Influenza Diagnostics Market Size by Type (2016-2021)
        9.2.2 Latin America Influenza Diagnostics Market Size by Type (2022-2027)
        9.2.3 Latin America Influenza Diagnostics Market Size by Type (2016-2027)
    9.3 Latin America Influenza Diagnostics Market Size by Application
        9.3.1 Latin America Influenza Diagnostics Market Size by Application (2016-2021)
        9.3.2 Latin America Influenza Diagnostics Market Size by Application (2022-2027)
        9.3.3 Latin America Influenza Diagnostics Market Size by Application (2016-2027)
    9.4 Latin America Influenza Diagnostics Market Size by Country
        9.4.1 Latin America Influenza Diagnostics Market Size by Country (2016-2021)
        9.4.2 Latin America Influenza Diagnostics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Influenza Diagnostics Market Size (2016-2027)
    10.2 Middle East & Africa Influenza Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Influenza Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Influenza Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 BD
        11.1.1 BD Company Details
        11.1.2 BD Business Overview
        11.1.3 BD Influenza Diagnostics Introduction
        11.1.4 BD Revenue in Influenza Diagnostics Business (2016-2021)
        11.1.5 BD Recent Development
    11.2 Abbott (Include Alere)
        11.2.1 Abbott (Include Alere) Company Details
        11.2.2 Abbott (Include Alere) Business Overview
        11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
        11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021)
        11.2.5 Abbott (Include Alere) Recent Development
    11.3 Roche
        11.3.1 Roche Company Details
        11.3.2 Roche Business Overview
        11.3.3 Roche Influenza Diagnostics Introduction
        11.3.4 Roche Revenue in Influenza Diagnostics Business (2016-2021)
        11.3.5 Roche Recent Development
    11.4 SIEMENS
        11.4.1 SIEMENS Company Details
        11.4.2 SIEMENS Business Overview
        11.4.3 SIEMENS Influenza Diagnostics Introduction
        11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2016-2021)
        11.4.5 SIEMENS Recent Development
    11.5 Analytik Jena
        11.5.1 Analytik Jena Company Details
        11.5.2 Analytik Jena Business Overview
        11.5.3 Analytik Jena Influenza Diagnostics Introduction
        11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021)
        11.5.5 Analytik Jena Recent Development
    11.6 Quidel
        11.6.1 Quidel Company Details
        11.6.2 Quidel Business Overview
        11.6.3 Quidel Influenza Diagnostics Introduction
        11.6.4 Quidel Revenue in Influenza Diagnostics Business (2016-2021)
        11.6.5 Quidel Recent Development
    11.7 Thermo Fisher
        11.7.1 Thermo Fisher Company Details
        11.7.2 Thermo Fisher Business Overview
        11.7.3 Thermo Fisher Influenza Diagnostics Introduction
        11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021)
        11.7.5 Thermo Fisher Recent Development
    11.8 Meridian Bioscience
        11.8.1 Meridian Bioscience Company Details
        11.8.2 Meridian Bioscience Business Overview
        11.8.3 Meridian Bioscience Influenza Diagnostics Introduction
        11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021)
        11.8.5 Meridian Bioscience Recent Development
    11.9 BioMerieux
        11.9.1 BioMerieux Company Details
        11.9.2 BioMerieux Business Overview
        11.9.3 BioMerieux Influenza Diagnostics Introduction
        11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2016-2021)
        11.9.5 BioMerieux Recent Development
    11.10 Sekisui Diagnostics
        11.10.1 Sekisui Diagnostics Company Details
        11.10.2 Sekisui Diagnostics Business Overview
        11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
        11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021)
        11.10.5 Sekisui Diagnostics Recent Development
    11.11 Response Biomedical
        11.11.1 Response Biomedical Company Details
        11.11.2 Response Biomedical Business Overview
        11.11.3 Response Biomedical Influenza Diagnostics Introduction
        11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021)
        11.11.5 Response Biomedical Recent Development
    11.12 SA Scientific
        11.12.1 SA Scientific Company Details
        11.12.2 SA Scientific Business Overview
        11.12.3 SA Scientific Influenza Diagnostics Introduction
        11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2016-2021)
        11.12.5 SA Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of RIDT Table 3. Key Players of RT-PCR Table 4. Key Players of Cell Culture Table 5. Key Players of Others Table 6. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Influenza Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Influenza Diagnostics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Influenza Diagnostics Market Share by Regions (2016-2021) Table 10. Global Influenza Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Influenza Diagnostics Market Share by Regions (2022-2027) Table 12. Influenza Diagnostics Market Trends Table 13. Influenza Diagnostics Market Drivers Table 14. Influenza Diagnostics Market Challenges Table 15. Influenza Diagnostics Market Restraints Table 16. Global Influenza Diagnostics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Influenza Diagnostics Market Share by Players (2016-2021) Table 18. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020) Table 19. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Influenza Diagnostics Product Solution and Service Table 23. Date of Enter into Influenza Diagnostics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021) Table 27. Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Influenza Diagnostics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Influenza Diagnostics Revenue Market Share by Application (2016-2021) Table 31. Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Influenza Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 63. BD Company Details Table 64. BD Business Overview Table 65. BD Influenza Diagnostics Product Table 66. BD Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 67. BD Recent Development Table 68. Abbott (Include Alere) Company Details Table 69. Abbott (Include Alere) Business Overview Table 70. Abbott (Include Alere) Influenza Diagnostics Product Table 71. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 72. Abbott (Include Alere) Recent Development Table 73. Roche Company Details Table 74. Roche Business Overview Table 75. Roche Influenza Diagnostics Product Table 76. Roche Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 77. Roche Recent Development Table 78. SIEMENS Company Details Table 79. SIEMENS Business Overview Table 80. SIEMENS Influenza Diagnostics Product Table 81. SIEMENS Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 82. SIEMENS Recent Development Table 83. Analytik Jena Company Details Table 84. Analytik Jena Business Overview Table 85. Analytik Jena Influenza Diagnostics Product Table 86. Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 87. Analytik Jena Recent Development Table 88. Quidel Company Details Table 89. Quidel Business Overview Table 90. Quidel Influenza Diagnostics Product Table 91. Quidel Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 92. Quidel Recent Development Table 93. Thermo Fisher Company Details Table 94. Thermo Fisher Business Overview Table 95. Thermo Fisher Influenza Diagnostics Product Table 96. Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 97. Thermo Fisher Recent Development Table 98. Meridian Bioscience Company Details Table 99. Meridian Bioscience Business Overview Table 100. Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 101. Meridian Bioscience Recent Development Table 102. BioMerieux Company Details Table 103. BioMerieux Business Overview Table 104. BioMerieux Influenza Diagnostics Product Table 105. BioMerieux Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 106. BioMerieux Recent Development Table 107. Sekisui Diagnostics Company Details Table 108. Sekisui Diagnostics Business Overview Table 109. Sekisui Diagnostics Influenza Diagnostics Product Table 110. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 111. Sekisui Diagnostics Recent Development Table 112. Response Biomedical Company Details Table 113. Response Biomedical Business Overview Table 114. Response Biomedical Influenza Diagnostics Product Table 115. Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 116. Response Biomedical Recent Development Table 117. SA Scientific Company Details Table 118. SA Scientific Business Overview Table 119. SA Scientific Influenza Diagnostics Product Table 120. SA Scientific Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million) Table 121. SA Scientific Recent Development Table 122. Research Programs/Design for This Report Table 123. Key Data Information from Secondary Sources Table 124. Key Data Information from Primary Sources List of Figures Figure 1. Global Influenza Diagnostics Market Share by Type: 2020 VS 2027 Figure 2. RIDT Features Figure 3. RT-PCR Features Figure 4. Cell Culture Features Figure 5. Others Features Figure 6. Global Influenza Diagnostics Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. POCT Case Studies Figure 9. Others Case Studies Figure 10. Influenza Diagnostics Report Years Considered Figure 11. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Influenza Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Influenza Diagnostics Market Share by Regions: 2020 VS 2027 Figure 14. Global Influenza Diagnostics Market Share by Regions (2022-2027) Figure 15. Global Influenza Diagnostics Market Share by Players in 2020 Figure 16. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2020 Figure 18. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021) Figure 19. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027) Figure 20. North America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Influenza Diagnostics Market Share by Type (2016-2027) Figure 22. North America Influenza Diagnostics Market Share by Application (2016-2027) Figure 23. North America Influenza Diagnostics Market Share by Country (2016-2027) Figure 24. United States Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Influenza Diagnostics Market Share by Type (2016-2027) Figure 28. Europe Influenza Diagnostics Market Share by Application (2016-2027) Figure 29. Europe Influenza Diagnostics Market Share by Country (2016-2027) Figure 30. Germany Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Influenza Diagnostics Market Share by Type (2016-2027) Figure 38. Asia-Pacific Influenza Diagnostics Market Share by Application (2016-2027) Figure 39. Asia-Pacific Influenza Diagnostics Market Share by Region (2016-2027) Figure 40. China Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Influenza Diagnostics Market Share by Type (2016-2027) Figure 48. Latin America Influenza Diagnostics Market Share by Application (2016-2027) Figure 49. Latin America Influenza Diagnostics Market Share by Country (2016-2027) Figure 50. Mexico Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Influenza Diagnostics Market Share by Type (2016-2027) Figure 54. Middle East & Africa Influenza Diagnostics Market Share by Application (2016-2027) Figure 55. Middle East & Africa Influenza Diagnostics Market Share by Country (2016-2027) Figure 56. Turkey Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. BD Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 60. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 61. Roche Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 62. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 63. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 64. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 65. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 66. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 67. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 68. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 69. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 70. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us